| Catalog_no |
ADMC0671 |
| Product_name |
Anacetrapib(MK0859) |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
2220.00/6440.00/10880.00 |
| Specificity |
Target: CETP. Fields: Anacetrapib (MK0859) is a potent, selective, reversible rhCETP and mutant CETP(C13S) inhibitor with IC50 of 7.9 nM and 11.8 nM, increases HDL-C and decreases LDL-C, does not increase aldosterone or blood pressure. Phase 3. |
| Dilution |
IC50: 7.9±2.5 nM (rhCETP), 11.8±1.9 nM (CETPC13S)[1] |
| Purification |
>98% |
| Concentration |
靶点：CETP;IC50： 7.9±2.5 nM (rhCETP), 11.8±1.9 nM (CETPC13S)[1] |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
MK-0859, MK 0859, MK0859 |
| Molecular Weight |
637.51 |
| Notes |
Anacetrapib (MK0859) is a potent, selective, reversible rhCETP and mutant CETP(C13S) inhibitor with IC50 of 7.9 nM and 11.8 nM, increases HDL-C and decreases LDL-C, does not increase aldosterone or blood pressure. Phase 3. |
| Instructions |
 查看与下载 |
